Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 4 3Phase EARLY_PHASE1 2Phase 3 2

Status

Completed 17Terminated 5Unknown 4Withdrawn 3Recruiting 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 2Infertility, Female 1Breast Neoplasms 1Breast Carcinoma In Situ 1Abortion, Spontaneous 1

Interventions

Metformin 3Letrozole 3Sperm Injections, Intracytoplasmic 2Progesterone 2Lidocaine 2Indocyanine Green 2Gentamicins 2Estradiol 2Clomiphene 2Bevacizumab 2Acitretin 2tirbanibulin 1technetium Tc 99m nanocolloid 1suvorexant 1pomalidomide 1pembrolizumab 1pasireotide 1nilotinib 1methylnaltrexone 1ledipasvir 1ixazomib 1gadolinium ethoxybenzyl DTPA 1gadofosveset trisodium 1exemestane 1encorafenib 1dolutegravir 1ceftolozane, tazobactam drug combination 1binimetinib 1bicalutamide 1apatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Withdrawn × Letrozole × Clear all
NCT05168865 2024-02-20

Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.

Dubai Fertility Center

Phase 4 Withdrawn

Abortion, Spontaneous, Polycystic Ovary Syndrome

NCT04002635 2021-01-08

LEFT

CRG UZ Brussel

Phase 4 Withdrawn

Infertility, Female, Polycystic Ovary Syndrome

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Fred Hutchinson Cancer Center

Phase 4 Withdrawn
Breast

Breast Carcinoma In Situ, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡